These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31776037)

  • 1. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
    Schlappe BA; Weaver AL; Ducie JA; Eriksson AGZ; Dowdy SC; Cliby WA; Glaser GE; Soslow RA; Alektiar KM; Makker V; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2018 Nov; 151(2):235-242. PubMed ID: 30177461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma.
    Basaran D; Bruce S; Aviki EM; Mueller JJ; Broach VA; Cadoo K; Soslow RA; Alektiar KM; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):70-76. PubMed ID: 31739992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm.
    Multinu F; Ducie JA; Eriksson AGZ; Schlappe BA; Cliby WA; Glaser GE; Grassi T; Keeney GL; Weaver AL; Abu-Rustum NR; Leitao MM; Mariani A
    Gynecol Oncol; 2019 Nov; 155(2):177-185. PubMed ID: 31604668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.
    Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and Obesity.
    Matanes E; Eisenberg N; Amajoud Z; Gupta V; Yasmeen A; Ismail S; Racovitan F; Raban O; Lau S; Salvador S; Gotlieb WH; Kogan L
    J Obstet Gynaecol Can; 2021 Oct; 43(10):1136-1144.e1. PubMed ID: 33984524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial cancer-how many patients could benefit from sentinel lymph node dissection?
    Brugger S; Hamann M; Mosner M; Beer M; Braun M; Pölcher M
    World J Surg Oncol; 2018 May; 16(1):95. PubMed ID: 29773071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
    Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
    Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
    Schiavone MB; Scelzo C; Straight C; Zhou Q; Alektiar KM; Makker V; Soslow RA; Iasonos A; Leitao MM; Abu-Rustum NR
    Ann Surg Oncol; 2017 Jul; 24(7):1965-1971. PubMed ID: 28258415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis.
    Lee D; Kim YN; Cho SH; Yoon HS; Kim YT; Kim S; Kim SW
    J Gynecol Oncol; 2023 Nov; 34(6):e79. PubMed ID: 37477102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
    Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
    J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting.
    Vidal F; Leguevaque P; Motton S; Delotte J; Ferron G; Querleu D; Rafii A
    Int J Gynecol Cancer; 2013 Sep; 23(7):1237-43. PubMed ID: 23839245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
    Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
    Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.